What this study is
This clinical trial aims to assess the impact of patient-focused and clinical-focused implementation strategies on blood pressure control. The investigators will assess the costs of these strategies and how effective they were at safely and equitably increasing home blood pressure monitoring.
What's being tested
- BP monitor use training and app training
Intervention · BEHAVIORAL
Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.
- Online patient portal enrollment and training
Intervention · BEHAVIORAL
Patients will receive training on how to use an online patient portal. If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.
- SMS reminders to take blood pressure
Intervention · BEHAVIORAL
Patients will receive reminders via SMS to take their blood pressure.
- Education about self-management of hypertension
Intervention · BEHAVIORAL
One-time training with action planning, access to website with language concordant patient education, and educational text messages
- Educational text messages that encourage seeking support from a support person
Intervention · BEHAVIORAL
Educational text messages about behavioral changes that explicitly encourage seeking support from a support person
- Involvement of caregiver or support person
Intervention · BEHAVIORAL
Patients will be asked to involve a caregiver or support person for all activities above, including patient portal proxy access.
- Group classes
Intervention · BEHAVIORAL
Patients will be asked to attend in-person or online group education classes on hypertension management
Study details
- Sponsor
- University of California, San Francisco
- Conditions
- Blood Pressure Monitoring, Home · Hypertension
- Enrolling
- 330 people
- Starts
- 2025-05-01
- Est. completion
- 2028-05-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- 18 years old/order
- Any sex or gender
- Any race or ethnicity
- Must be receiving primary care at any of the six enrolled clinics
- Have uncontrolled hypertension (two clinic BP readings ≥140/90 mmHg within the previous 18 months)
- Can read and write English, Spanish, or Cantonese
- Be able to provide consent
- Must own a cell phone that receives SMS or text messages
You can't join if
- Those with conditions that might complicate remote BP monitoring:; Pregnancy (and 12 months postpartum); Acute myocardial infarction or stroke in the last 12 months; End-stage renal disease on dialysis; Stage D heart failure; Active treatment for cancer (except for nonmelanoma skin cancers); Pacemaker use
- Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openZuckerberg San Francisco General Hospital
San Francisco, California, United States
Study team
Sponsor
University of California, San Francisco
Study ID 24-42092
Principal investigator
Elaine Khoong, MD, MS
University of California, San Francisco
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.